Christopher Grant
Executive Vice President and Chief Operating Officer @ Kaiser Permanente Ventures
Pleasanton, United States
Christopher Grant is a Series B investor at Kaiser Permanente Ventures in Pleasanton focused on Health Care and Mobile. Christopher M. Grant is based out of Pleasanton, California and is the Executive Vice President and Chief Operating Officer of Kaiser Permanente Ventures. Christopher previously worked at Rockwell International as a Business Development and Financial Manageme. Christopher M. Grant attended the University of California, Santa Barbara.
- Total investments:
- 5
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Christopher Grant invests in
Stages Christopher Grant invests in
Countries Christopher Grant invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 3 (60%)
- Mobile 1 (20%)
- Medical 1 (20%)
- Hospital 1 (20%)
- Automotive 1 (20%)
Stage
- Series B 1 (20%)
- Series D 1 (20%)
- Series E 1 (20%)
- Funding Round 1 (20%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Torax Medical, Inc., a clinical stage medical device company, develops an implantable device for the treatment of gastroesophageal reflux disease. It provides treatments for digestive diseases, including acid reflux. The company was founded in 2002 and is based in Shoreview, Minnesota. | $25M / Series E / Jul 26, 2016 | ||
| Xanitos is a management company that provides hospital housekeeping, patient transport, and central laundries services. It is differentiated by its patent pending XRO system for cleaning patient rooms, its outstanding operations management team, and by being a private company whose priority is giving top quality service, believing that by so doing,profits will follow.Graeme Crothall, founder and CEO, has 40 years’ experience in hospital housekeeping and during that time he has founded and led four successful companies in the industry whose revenues today exceed $2.5 billion. In 2008 Graeme founded Xanitos by acquiring two small companies, one of which owned the XRO patient room cleaning system, and continuing his track-record of providing top quality service, attracting and holding excellent operations management, and always growing the companies he leads.The results are evident; at the hospitals it serves, Xanitos has improved the cleaning quality, increased HCAHPS scores, reduced the risk of HAIs, lowered bed turn around time, and significantly reduced costs. | $7M / Sep 20, 2013 | ||
| Torax Medical, Inc., a clinical stage medical device company, develops an implantable device for the treatment of gastroesophageal reflux disease. It provides treatments for digestive diseases, including acid reflux. The company was founded in 2002 and is based in Shoreview, Minnesota. | $30M / Series D / Sep 19, 2012 | ||
| Xanitos is a management company that provides hospital housekeeping, patient transport, and central laundries services. It is differentiated by its patent pending XRO system for cleaning patient rooms, its outstanding operations management team, and by being a private company whose priority is giving top quality service, believing that by so doing,profits will follow.Graeme Crothall, founder and CEO, has 40 years’ experience in hospital housekeeping and during that time he has founded and led four successful companies in the industry whose revenues today exceed $2.5 billion. In 2008 Graeme founded Xanitos by acquiring two small companies, one of which owned the XRO patient room cleaning system, and continuing his track-record of providing top quality service, attracting and holding excellent operations management, and always growing the companies he leads.The results are evident; at the hospitals it serves, Xanitos has improved the cleaning quality, increased HCAHPS scores, reduced the risk of HAIs, lowered bed turn around time, and significantly reduced costs. | $9M / Nov 14, 2011 | ||
| Proteus Digital Health® is creating a new category of pharmaceuticals: Digital Medicines. Digital Medicines includes drugs that communicate when they’ve been taken, wearable sensors that capture physiologic response, applications that support patient self-care and physician decision making and data analytics to serve the needs of doctors and healthsystems. The goal of Digital Medicines is to empower patients and their families, enable physicians and health systems to more effectively manage risk and ensure that outcomes are reliably achieved. | $6.3M / Series B / Jun 23, 2004 |
Co-Investors
Kaiser Permanente Ventures, the corporate venture capital arm of Kaiser Permanente, is dedicated to forming effective partnerships with innovative companies. Kaiser Permanente Ventures invests predominantly in HCIT and services, as well as diagnostics, drug delivery and therapeutic medical devices.
Kaiser Permanente Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Amy Belt Raimundo
Managing Director
|
|||
Bryan Sivak
Managing Director
|
|||
|
Christopher Grant
Executive Vice President and Chief Operating Officer
|
|||
Jodie Ha
Associate
|
|||
Liz Rockett
Managing Director
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Christopher Grant invest in?
Christopher Grant invests primarily in Health Care, Mobile and Medical startups, most often at Series B and Series D stage. Most of the 5 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Christopher Grant?
Public channels for Christopher Grant include LinkedIn and X (Twitter). For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Christopher Grant last invest?
The most recent investment recorded for Christopher Grant closed in Jul 2016. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
